1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Non-invasive
Prenatal Testing (NIPT) Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Consumables, Instruments)
5.2.2. By Test Type (Materni 21, Harmony, Panaroma,
Verifi, NIFTY, Others)
5.2.3. By Method (Ultrasound Detection, Biochemical
Screening Testing, Cell-Free DNA Maternal Plasma Tests, Fetal Cells in Maternal
Blood Tests, Others)
5.2.4. By Application (Trisomy, Microdeletion
Syndrome, Others)
5.2.5. By End User (Diagnostic Laboratories,
Hospitals, Others)
5.2.6. By Region
5.2.7. By Company (2022)
5.3. Market Map
6.
North America Non-invasive
Prenatal Testing (NIPT) Market Outlook
6.1.
Market Size &
Forecast
6.1.1. By Value
6.2.
Market Share &
Forecast
6.2.1.
By Product Type
6.2.2.
By Test Type
6.2.3.
By Method
6.2.4.
By Application
6.2.5.
By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Non-invasive Prenatal Testing
(NIPT) Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product Type
6.3.1.2.2.
By Test Type
6.3.1.2.3.
By Method
6.3.1.2.4.
By Application
6.3.1.2.5.
By End User
6.3.2. Canada Non-invasive Prenatal Testing (NIPT)
Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product Type
6.3.2.2.2.
By Test Type
6.3.2.2.3.
By Method
6.3.2.2.4.
By Application
6.3.2.2.5.
By End User
6.3.3. Mexico Non-invasive Prenatal Testing (NIPT)
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product Type
6.3.3.2.2.
By Test Type
6.3.3.2.3.
By Method
6.3.3.2.4.
By Application
6.3.3.2.5.
By End User
7.
Europe Non-invasive
Prenatal Testing (NIPT) Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Test Type
7.2.3. By Method
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Non-invasive Prenatal Testing (NIPT)
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product Type
7.3.1.2.2.
By Test Type
7.3.1.2.3.
By Method
7.3.1.2.4.
By Application
7.3.1.2.5.
By End User
7.3.2. United Kingdom Non-invasive Prenatal Testing
(NIPT) Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product Type
7.3.2.2.2.
By Test Type
7.3.2.2.3.
By Method
7.3.2.2.4.
By Application
7.3.2.2.5.
By End User
7.3.3. Italy Non-invasive Prenatal Testing (NIPT)
Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecasty
7.3.3.2.1.
By Product Type
7.3.3.2.2.
By Test Type
7.3.3.2.3.
By Method
7.3.3.2.4.
By Application
7.3.3.2.5.
By End User
7.3.4. France Non-invasive Prenatal Testing (NIPT)
Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product Type
7.3.4.2.2.
By Test Type
7.3.4.2.3.
By Method
7.3.4.2.4.
By Application
7.3.4.2.5.
By End User
7.3.5. Spain Non-invasive Prenatal Testing (NIPT)
Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product Type
7.3.5.2.2.
By Test Type
7.3.5.2.3.
By Method
7.3.5.2.4.
By Application
7.3.5.2.5.
By End User
8.
Asia-Pacific Non-invasive
Prenatal Testing (NIPT) Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Test Type
8.2.3. By Method
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Non-invasive Prenatal Testing (NIPT)
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product Type
8.3.1.2.2.
By Test Type
8.3.1.2.3.
By Method
8.3.1.2.4.
By Application
8.3.1.2.5.
By End User
8.3.2. India Non-invasive Prenatal Testing (NIPT)
Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product Type
8.3.2.2.2.
By Test Type
8.3.2.2.3.
By Method
8.3.2.2.4.
By Application
8.3.2.2.5.
By End User
8.3.3. Japan Non-invasive Prenatal Testing (NIPT)
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product Type
8.3.3.2.2.
By Test Type
8.3.3.2.3.
By Method
8.3.3.2.4.
By Application
8.3.3.2.5.
By End User
8.3.4. South Korea Non-invasive Prenatal Testing
(NIPT) Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product Type
8.3.4.2.2.
By Test Type
8.3.4.2.3.
By Method
8.3.4.2.4.
By Application
8.3.4.2.5.
By End User
8.3.5. Australia Non-invasive Prenatal Testing (NIPT)
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product Type
8.3.5.2.2.
By Test Type
8.3.5.2.3.
By Method
8.3.5.2.4.
By Application
8.3.5.2.5.
By End User
9.
South America Non-invasive
Prenatal Testing (NIPT) Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Test Type
9.2.3. By Method
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Non-invasive Prenatal Testing (NIPT)
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product Type
9.3.1.2.2.
By Test Type
9.3.1.2.3.
By Method
9.3.1.2.4.
By Application
9.3.1.2.5.
By End User
9.3.2. Argentina Non-invasive Prenatal Testing (NIPT)
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product Type
9.3.2.2.2.
By Test Type
9.3.2.2.3.
By Method
9.3.2.2.4.
By Application
9.3.2.2.5.
By End User
9.3.3. Colombia Non-invasive Prenatal Testing (NIPT)
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product Type
9.3.3.2.2.
By Test Type
9.3.3.2.3.
By Method
9.3.3.2.4.
By Application
9.3.3.2.5.
By End User
10.
Middle East and
Africa Non-invasive Prenatal Testing (NIPT) Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1. By Product Type
10.2.2. By Test Type
10.2.3. By Method
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Non-invasive Prenatal Testing
(NIPT) Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Product Type
10.3.1.2.2.
By Test Type
10.3.1.2.3.
By Method
10.3.1.2.4.
By Application
10.3.1.2.5.
By End User
10.3.2. Saudi Arabia Non-invasive Prenatal Testing
(NIPT) Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Product Type
10.3.2.2.2.
By Test Type
10.3.2.2.3.
By Method
10.3.2.2.4.
By Application
10.3.2.2.5.
By End User
10.3.3. UAE Non-invasive Prenatal Testing (NIPT)
Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Product Type
10.3.3.2.2.
By Test Type
10.3.3.2.3.
By Method
10.3.3.2.4.
By Application
10.3.3.2.5.
By End User
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13.
Global Oral Clinical Nutrition Market: SWOT Analysis
14.
Porter’s Five Forces Analysis
14.1.
Competition in the
Industry
14.2.
Potential of New
Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute
Products
15. Competitive Landscape
15.1.
Business Overview
15.2.
Service Offerings
15.3.
Recent Developments
15.4.
Key Personnel
15.5.
SWOT Analysis
15.5.1. YOURGENE HEALTH Plc
15.5.2. Illumina, Inc.
15.5.3. Natera, Inc.
15.5.4. F.Hoffman La Roche Ltd.
15.5.5. Perkin Elmer Inc.
15.5.6. Laboratory Corporation of America
Holdings
15.5.7. Eurofins LifeCodex GmbH
15.5.8. Progenity, Inc.
15.5.9. Genesis Genetics
15.5.10.
Quest Diagnostics Incorporated
16.
Strategic Recommendations
17. About Us & Disclaimer